163 related articles for article (PubMed ID: 11693171)
1. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
2. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
4. Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors.
Siegrist W; Willard DH; Wilkison WO; Eberle AN
Biochem Biophys Res Commun; 1996 Jan; 218(1):171-5. PubMed ID: 8573126
[TBL] [Abstract][Full Text] [Related]
5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
6. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
7. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
8. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
9. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.
Boston BA; Cone RD
Endocrinology; 1996 May; 137(5):2043-50. PubMed ID: 8612546
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
11. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
12. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone.
Graham A; Wakamatsu K; Hunt G; Ito S; Thody AJ
Pigment Cell Res; 1997 Oct; 10(5):298-303. PubMed ID: 9359625
[TBL] [Abstract][Full Text] [Related]
13. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
[TBL] [Abstract][Full Text] [Related]
14. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells.
Mountjoy KG; Kong PL; Taylor JA; Willard DH; Wilkison WO
Physiol Genomics; 2001 Feb; 5(1):11-9. PubMed ID: 11161002
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
[TBL] [Abstract][Full Text] [Related]
16. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 153N-6 analogues and structure-function analysis at murine melanocortin-1 (MC1) receptors.
Sahm UG; Olivier GW; Pouton CW
Peptides; 1999; 20(3):387-94. PubMed ID: 10447099
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of melanocortin receptor signaling mediated by the amino terminus of Agouti protein in Xenopus melanophores.
Ollmann MM; Barsh GS
J Biol Chem; 1999 May; 274(22):15837-46. PubMed ID: 10336487
[TBL] [Abstract][Full Text] [Related]
19. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors.
Holst B; Elling CE; Schwartz TW
J Biol Chem; 2002 Dec; 277(49):47662-70. PubMed ID: 12244039
[TBL] [Abstract][Full Text] [Related]
20. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
